Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
211M
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
57.8M
-
Shares change
-
+314K
-
Total reported value, excl. options
-
$765M
-
Value change
-
+$2.35M
-
Put/Call ratio
-
0.21
-
Number of buys
-
49
-
Number of sells
-
-36
-
Price
-
$13.23
Significant Holders of INSMED Inc - Common Stock, par value $0.01 per share (INSM) as of Q4 2016
112 filings reported holding INSM - INSMED Inc - Common Stock, par value $0.01 per share as of Q4 2016.
INSMED Inc - Common Stock, par value $0.01 per share (INSM) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.8M shares
of 211M outstanding shares and own 27.41% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (10.5M shares), FMR LLC (9.28M shares), Palo Alto Investors, LLC (5.45M shares), ORBIMED ADVISORS LLC (5.3M shares), VANGUARD GROUP INC (3.61M shares), JANUS CAPITAL MANAGEMENT LLC (2.86M shares), BlackRock Fund Advisors (2.71M shares), JPMORGAN CHASE & CO (1.57M shares), BlackRock Institutional Trust Company, N.A. (1.56M shares), and STATE STREET CORP (1.43M shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.